Leverages Innovative Technologies, Personalized Approach for Medication-free Treatment Options Medford, N.Y., – September 9, 2020 — Long Island NeuroCare Therapy, the flagship neuroCare Centers of
neuroCare and Kyowa sign an equity participation paving the way for a strategic joint venture in Japan neuroCare Group GmbH (“neuroCare”) personalizes mental health therapy
Become a NeuroStar – watch this video and see why NeuroStar can help make long-term remission from depression possible. Contact us today for TMS Therapy!
A study published recently in the American Journal of Epidemiology found that a strong association between even low-level nighttime light exposure and depressive symptoms among
While acknowledging that treatment with medication for attention deficit hyperactivity disorder (ADHD) is effective in the short term, researchers of a meta-analysis literature review have
Researchers compare methods of treating ADHD in children and find that Neurofeedback, a medication-free technique, has long-lasting effects up to 12 months A study just
© 2022 All rights reserved
